Pharvaris Net Invested Capital vs Other Stockholder Equity Analysis

PHVS Stock

USD 22.29 1.25 5.94%

Pharvaris financial indicator trend analysis is much more than just breaking down Pharvaris BV prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharvaris BV is a good investment. Please check the relationship between Pharvaris Net Invested Capital and its Other Stockholder Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Net Invested Capital vs Other Stockholder Equity

Net Invested Capital vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharvaris BV Net Invested Capital account and Other Stockholder Equity. At this time, the significance of the direction appears to have totally related.

The correlation between Pharvaris' Net Invested Capital and Other Stockholder Equity is 1.0. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Pharvaris BV, assuming nothing else is changed. The correlation between historical values of Pharvaris' Net Invested Capital and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Pharvaris BV are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Net Invested Capital i.e., Pharvaris' Net Invested Capital and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Other Stockholder Equity

Most indicators from Pharvaris' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharvaris BV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

At this time, Pharvaris' Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 66 M in 2024, whereas Selling General Administrative is likely to drop slightly above 16 M in 2024.

Pharvaris fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Common Stock	Net Tangible Assets	Other Current Assets	Capital Stock	Property Plant And Equipment Net	Property Plant And Equipment Gross	Property Plant Equipment	Inventory	Short Long Term Debt Total
Total Assets		0.8	0.76	1.0	-1.0	-0.97	0.64	1.0	1.0	0.97	0.32	-0.06	1.0	0.76	1.0	1.0	1.0	0.97	0.81	0.94	0.97	0.79	0.82	0.95	-0.08	0.1
Other Current Liab	0.8		0.82	0.79	-0.79	-0.9	0.74	0.8	0.8	0.74	0.27	0.1	0.84	0.82	0.79	0.8	0.79	0.79	0.57	0.94	0.79	0.76	0.78	0.87	0.14	0.45
Total Current Liabilities	0.76	0.82		0.75	-0.78	-0.84	0.96	0.76	0.76	0.73	0.3	0.14	0.78	1.0	0.75	0.76	0.75	0.82	0.86	0.88	0.82	0.96	0.97	0.88	0.51	0.65
Total Stockholder Equity	1.0	0.79	0.75		-1.0	-0.97	0.63	1.0	1.0	0.97	0.32	-0.06	1.0	0.75	1.0	1.0	1.0	0.97	0.81	0.94	0.97	0.78	0.81	0.94	-0.1	0.08
Net Debt	-1.0	-0.79	-0.78	-1.0		0.97	-0.65	-1.0	-1.0	-0.97	-0.33	0.05	-0.99	-0.78	-1.0	-1.0	-1.0	-0.97	-0.83	-0.94	-0.97	-0.8	-0.83	-0.94	0.06	-0.1
Retained Earnings	-0.97	-0.9	-0.84	-0.97	0.97		-0.75	-0.97	-0.97	-0.91	-0.34	0.08	-0.99	-0.84	-0.97	-0.97	-0.97	-0.97	-0.78	-0.98	-0.97	-0.86	-0.88	-0.98	-0.04	-0.26
Accounts Payable	0.64	0.74	0.96	0.63	-0.65	-0.75		0.64	0.64	0.59	0.25	0.07	0.66	0.96	0.63	0.64	0.62	0.75	0.79	0.8	0.75	0.97	0.95	0.83	0.69	0.8
Cash	1.0	0.8	0.76	1.0	-1.0	-0.97	0.64		1.0	0.97	0.32	-0.06	1.0	0.76	1.0	1.0	1.0	0.97	0.81	0.94	0.97	0.79	0.81	0.94	-0.08	0.09
Cash And Short Term Investments	1.0	0.8	0.76	1.0	-1.0	-0.97	0.64	1.0		0.97	0.32	-0.06	1.0	0.76	1.0	1.0	1.0	0.97	0.81	0.94	0.97	0.79	0.81	0.94	-0.08	0.09
Net Receivables	0.97	0.74	0.73	0.97	-0.97	-0.91	0.59	0.97	0.97		0.21	0.16	0.96	0.73	0.97	0.97	0.97	0.91	0.85	0.89	0.91	0.73	0.75	0.87	-0.1	0.04
Common Stock Shares Outstanding	0.32	0.27	0.3	0.32	-0.33	-0.34	0.25	0.32	0.32	0.21		-0.42	0.32	0.3	0.32	0.32	0.32	0.34	0.29	0.36	0.34	0.34	0.36	0.35	0.05	0.13
Non Current Liabilities Total	-0.06	0.1	0.14	-0.06	0.05	0.08	0.07	-0.06	-0.06	0.16	-0.42		-0.07	0.14	-0.06	-0.06	-0.06	-0.17	0.17	0.01	-0.17	-0.05	-0.06	-0.14	0.15	0.11
Other Stockholder Equity	1.0	0.84	0.78	1.0	-0.99	-0.99	0.66	1.0	1.0	0.96	0.32	-0.07		0.78	1.0	1.0	1.0	0.98	0.79	0.96	0.98	0.8	0.83	0.96	-0.06	0.14
Total Liab	0.76	0.82	1.0	0.75	-0.78	-0.84	0.96	0.76	0.76	0.73	0.3	0.14	0.78		0.75	0.76	0.75	0.82	0.86	0.88	0.82	0.97	0.97	0.88	0.51	0.65
Net Invested Capital	1.0	0.79	0.75	1.0	-1.0	-0.97	0.63	1.0	1.0	0.97	0.32	-0.06	1.0	0.75		1.0	1.0	0.97	0.81	0.94	0.97	0.78	0.81	0.94	-0.1	0.08
Total Current Assets	1.0	0.8	0.76	1.0	-1.0	-0.97	0.64	1.0	1.0	0.97	0.32	-0.06	1.0	0.76	1.0		1.0	0.97	0.81	0.94	0.97	0.79	0.82	0.95	-0.08	0.1
Net Working Capital	1.0	0.79	0.75	1.0	-1.0	-0.97	0.62	1.0	1.0	0.97	0.32	-0.06	1.0	0.75	1.0	1.0		0.97	0.81	0.94	0.97	0.78	0.81	0.94	-0.1	0.08
Common Stock	0.97	0.79	0.82	0.97	-0.97	-0.97	0.75	0.97	0.97	0.91	0.34	-0.17	0.98	0.82	0.97	0.97	0.97		0.84	0.94	1.0	0.88	0.9	0.98	0.09	0.25
Net Tangible Assets	0.81	0.57	0.86	0.81	-0.83	-0.78	0.79	0.81	0.81	0.85	0.29	0.17	0.79	0.86	0.81	0.81	0.81	0.84		0.78	0.84	0.88	0.88	0.81	0.33	0.34
Other Current Assets	0.94	0.94	0.88	0.94	-0.94	-0.98	0.8	0.94	0.94	0.89	0.36	0.01	0.96	0.88	0.94	0.94	0.94	0.94	0.78		0.94	0.87	0.89	0.97	0.14	0.38
Capital Stock	0.97	0.79	0.82	0.97	-0.97	-0.97	0.75	0.97	0.97	0.91	0.34	-0.17	0.98	0.82	0.97	0.97	0.97	1.0	0.84	0.94		0.88	0.9	0.98	0.09	0.25
Property Plant And Equipment Net	0.79	0.76	0.96	0.78	-0.8	-0.86	0.97	0.79	0.79	0.73	0.34	-0.05	0.8	0.97	0.78	0.79	0.78	0.88	0.88	0.87	0.88		1.0	0.92	0.52	0.64
Property Plant And Equipment Gross	0.82	0.78	0.97	0.81	-0.83	-0.88	0.95	0.81	0.81	0.75	0.36	-0.06	0.83	0.97	0.81	0.82	0.81	0.9	0.88	0.89	0.9	1.0		0.94	0.47	0.6
Property Plant Equipment	0.95	0.87	0.88	0.94	-0.94	-0.98	0.83	0.94	0.94	0.87	0.35	-0.14	0.96	0.88	0.94	0.95	0.94	0.98	0.81	0.97	0.98	0.92	0.94		0.2	0.39
Inventory	-0.08	0.14	0.51	-0.1	0.06	-0.04	0.69	-0.08	-0.08	-0.1	0.05	0.15	-0.06	0.51	-0.1	-0.08	-0.1	0.09	0.33	0.14	0.09	0.52	0.47	0.2		0.93
Short Long Term Debt Total	0.1	0.45	0.65	0.08	-0.1	-0.26	0.8	0.09	0.09	0.04	0.13	0.11	0.14	0.65	0.08	0.1	0.08	0.25	0.34	0.38	0.25	0.64	0.6	0.39	0.93

Click cells to compare fundamentals

Pharvaris Account Relationship Matchups

Pharvaris fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	20.6M	101.1M	212.1M	167.7M	398.7M	418.6M
Other Current Liab	1.4M	4.5M	(2.5M)	10.9M	11.1M	11.6M
Total Current Liabilities	1.9M	5.3M	7.0M	18.2M	14.6M	7.5M
Total Stockholder Equity	18.7M	95.8M	205.0M	149.3M	384.0M	403.3M
Net Debt	(20.3M)	(98.6M)	(209.1M)	(161.4M)	(391.0M)	(371.4M)
Retained Earnings	(18.5M)	(44.5M)	(87.6M)	(164.2M)	(265.9M)	(252.6M)
Accounts Payable	509.9K	656.4K	2.1M	6.0M	2.9M	2.0M
Cash	20.3M	98.6M	209.4M	161.8M	391.2M	410.8M
Non Current Assets Total	12.9K	147.8K	523.4K	886.2K	843.1K	885.3K
Cash And Short Term Investments	20.3M	98.6M	209.4M	161.8M	391.6M	411.1M
Net Receivables	210.8K	569.6K	700.1K	382.5K	1.0M	1.1M
Liabilities And Stockholders Equity	20.6M	101.1M	212.1M	167.7M	398.7M	418.6M
Non Current Liabilities Total	509.9K	847.0K	150.8K	249.4K	43.6K	41.4K
Other Stockholder Equity	36.5M	138.0M	278.7M	289.2M	615.8M	646.6M
Total Liab	1.9M	5.3M	7.1M	18.5M	14.6M	7.6M
Net Invested Capital	18.7M	95.8M	205.0M	149.3M	384.0M	403.3M
Total Current Assets	20.6M	101.0M	211.6M	166.8M	397.9M	417.7M
Accumulated Other Comprehensive Income	392.1K	2.0M	9.8M	20.2M	27.9M	29.3M
Net Working Capital	18.7M	95.6M	204.6M	148.6M	383.2M	402.4M
Common Stock	131.0K	235.7K	4.0M	4.1M	6.3M	6.6M
Net Tangible Assets	18.6M	95.6M	205.0M	149.3M	171.6M	104.1M
Other Current Assets	47.5K	1.8M	1.5M	4.6M	5.6M	5.9M
Capital Stock	131.0K	235.7K	4.0M	4.1M	6.3M	6.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC